Search

Your search keyword '"Pellicano, Chiara"' showing total 219 results
Start Over Author "Pellicano, Chiara"
219 results on '"Pellicano, Chiara"'

5. Diffusing Capacity of the Lungs for Carbon Monoxide and Echocardiographic Parameters in Identifying Mild Pulmonary Hypertension in the EUSTAR Cohort of Patients With Systemic Sclerosis

Author

Distler, Oliver, Becker, Mike, De Decker, Melissa, Fegatelli, Danilo Alunni, Siegert, Elise, Castellví, Ivan, Cauli, Alberto, Solanki, Kamal, Dagna, Lorenzo, Martin, Mickaël, Moroncini, Gianluca, Poormoghim, Hadi, Kuwana, Masataka, Carreira, Patricia E., Airò, Paolo, Bergmann, Christina, Spierings, Julia, Tanaka, Yoshiya, Selvi, Enrico, Soukup, Tomas, Colalillo, Amalia, Hachulla, Eric, Pellicano, Chiara, Smith, Vanessa, Riemekasten, Gabriela, Zanatta, Elisabetta, Henes, Jörg, Launay, David, Marcoccia, Antonella, Gheorghiu, Ana Maria, Truchetet, Marie-Elise, Iannone, Florenzo, Simeón Aznar, Carmen Pilar, Oliveira, Susana, Vonk, Madelon, Del Galdo, Francesco, and Rosato, Edoardo

Published
2024
Full Text
View/download PDF

28. Diffusing Capacity of the Lungs for Carbon Monoxide and Echocardiographic Parameters in Identifying Mild Pulmonary Hypertension in the EUSTAR Cohort of Patients With Systemic Sclerosis.

Author

Colalillo, Amalia, Hachulla, Eric, Pellicano, Chiara, Smith, Vanessa, Bergmann, Christina, Riemekasten, Gabriela, Zanatta, Elisabetta, Henes, Jörg, Launay, David, Marcoccia, Antonella, Gheorghiu, Ana Maria, Truchetet, Marie-Elise, Iannone, Florenzo, Simeón Aznar, Carmen Pilar, Oliveira, Susana, Vonk, Madelon, Del Galdo, Francesco, and Rosato, Edoardo

Subjects
LUNG volume measurements, CARBON monoxide, SYSTEMIC scleroderma, PULMONARY hypertension, PULMONARY artery
Abstract

The 2022 European Society of Cardiology/European Respiratory Society guidelines define pulmonary hypertension (PH) as a resting mean pulmonary artery pressure (mPAP) > 20 mm Hg at right heart catheterization (RHC). Previously, patients with an mPAP between 21 and 24 mm Hg were classified in a "gray zone" of unclear clinical significance. What is the diagnostic performance of the main parameters used for PH screening in detecting patients with systemic sclerosis (SSc) with an mPAP of 21 to 24 mm Hg at RHC? Patients with SSc from the European Scleroderma Trials and Research (EUSTAR) database with available tricuspid annular plane systolic excursion (TAPSE), systolic PAP (sPAP), and mPAP data were included. Patients with mPAP 21 to 24 mm Hg and patients with mPAP ≤ 20 mm Hg were considered for the analysis. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy were calculated. TAPSE/sPAP was lower in the group of patients with SSc with mPAP 21 to 24 mm Hg than in the non-PH group (0.58 [0.46-0.72] vs 0.69 [0.57-0.81] mm/mm Hg, respectively; P <.01). No difference was found in other parameters between the two groups. Diffusing capacity of the lungs for carbon monoxide < 80% of the predicted value had the highest sensitivity (88.9%) and NPV (80%), but the lowest specificity (18.2%) and PPV (30.8%) in detecting patients with SSc with mPAP 21 to 24 mm Hg. TAPSE/sPAP < 0.55 mm/mm Hg had the highest specificity (78.9%), PPV (50%), and accuracy (68.1%); its NPV was 75.4%, and its sensitivity was 45.1%. In this study, diffusing capacity of the lungs for carbon monoxide < 80% of the predicted value was the parameter with the highest sensitivity and NPV in detecting patients with SSc with mPAP 21 to 24 mm Hg. TAPSE/sPAP < 0.55 mm/mm Hg had the highest specificity, PPV, and accuracy and, therefore, can be a useful additional parameter to decrease the number of unnecessary RHCs. [Display omitted] [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

29. COVID-19 Infection in Autosomal Dominant Polycystic Kidney Disease and Chronic Kidney Disease Patients: Progression of Kidney Disease

Author

Lai, Silvia, primary, Tinti, Francesca, additional, Perrotta, Adolfo Marco, additional, Salomone, Luca, additional, Cianci, Rosario, additional, Izzo, Paolo, additional, Izzo, Sara, additional, Izzo, Luciano, additional, De Intinis, Claudia, additional, Pellicano, Chiara, additional, and Gigante, Antonietta, additional

Published
2024
Full Text
View/download PDF

30. DLco and echocardiographic parameters in identifying mild pulmonary hypertension in the EUSTAR cohort of systemic sclerosis patients

Author

Colalillo, Amalia, primary, Hachulla, Eric, additional, Pellicano, Chiara, additional, Smith, Vanessa, additional, Bergmann, Christina, additional, Riemekasten, Gabriela, additional, Zanatta, Elisabetta, additional, Henes, Jörg, additional, Launay, David, additional, Marcoccia, Antonella, additional, Gheorghiu, Ana Maria, additional, Truchetet, Marie-Elise, additional, Iannone, Florenzo, additional, Simeón Aznar, Carmen Pilar, additional, Oliveira, Susana, additional, Vonk, Madelon, additional, Del Galdo, Francesco, additional, Rosato, Edoardo, additional, Distler, Oliver, additional, Becker, Mike, additional, De Decker, Melissa, additional, Fegatelli, Danilo Alunni, additional, Siegert, Elise, additional, Castellví, Ivan, additional, Cauli, Alberto, additional, Solanki, Kamal, additional, Dagna, Lorenzo, additional, Martin, Mickaël, additional, Moroncini, Gianluca, additional, Poormoghim, Hadi, additional, Kuwana, Masataka, additional, Carreira, Patricia E., additional, Airò, Paolo, additional, Spierings, Julia, additional, Tanaka, Yoshiya, additional, Selvi, Enrico, additional, and Soukup, Tomas, additional

Published
2024
Full Text
View/download PDF

34. Reciprocal effects of scleroderma and temporomandibular dysfunction between patient cohorts.

Author

Pellicano, Chiara, Leodori, Giorgia, Floridia, Stefano, Colalillo, Amalia, Gigante, Antonietta, Rosato, Edoardo, and Paoloni, Marco

Subjects
TEMPOROMANDIBULAR disorders, SYSTEMIC scleroderma, SYMPTOMS
Abstract

Objective: To estimate the prevalence of temporomandibular dysfunction in scleroderma patients according to the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) and to correlate it with disease variables. Methods: Temporomandibular dysfunction was evaluated in 75 scleroderma patients and 74 healthy controls using DC/TMD. Gastrointestinal symptoms were evaluated through the University of California Los Angeles (UCLA) score in scleroderma patients. Results: There was no difference of prevalence in temporomandibular dysfunction [30 (40%) vs 30 (40.5%); p > 00.05] between scleroderma patients and healthy controls. Scleroderma patients had a significant reduction in all oral movements compared to healthy controls. Scleroderma patients with temporomandibular dysfunction had a statistically higher score in the UCLA distention/bloating item [1.75 (0.5–2.38) vs 0.75 (0.25–1.75); p < 0.05] than scleroderma patients without temporomandibular dysfunction. Discussion: Temporomandibular dysfunction prevalence between scleroderma patients and healthy controls is similar. In scleroderma patients, temporomandibular dysfunction reduces oral mobility and opening, which worsens distension/bloating. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

36. Kidney Biopsy and Immuno-Rheumatological Diseases: A Retrospective and Observational Study

Author

Gigante, Antonietta, primary, Cianci, Rosario, additional, Villa, Annalisa, additional, Pellicano, Chiara, additional, Giannakakis, Konstantinos, additional, Rosato, Edoardo, additional, Spinelli, Francesca Romana, additional, Basile, Umberto, additional, Racco, Cosimo, additional, Di Virgilio, Elena Maria, additional, Cerbelli, Bruna, additional, and Conti, Fabrizio, additional

Published
2024
Full Text
View/download PDF

43. Contrast-Induced Acute Kidney Injury and Endothelial Dysfunction: The Role of Vascular and Biochemical Parameters

Author

Perrotta, Adolfo Marco, primary, Gigante, Antonietta, additional, Rotondi, Silverio, additional, Menè, Paolo, additional, Notturni, Adriano, additional, Schiavetto, Stefano, additional, Tanzilli, Gaetano, additional, Pellicano, Chiara, additional, Guaglianone, Giuseppe, additional, Tinti, Francesca, additional, Palange, Paolo, additional, Mazzaferro, Sandro, additional, Cianci, Rosario, additional, and Lai, Silvia, additional

Published
2023
Full Text
View/download PDF

44. Serum Immunoglobulin G (IgG) Subclasses in a Cohort of Systemic Sclerosis Patients

Author

Pellicano, Chiara, Colalillo, Amalia, Cusano, Giuseppina, Palladino, Andrea, Pellegrini, Marica, Calla', Cinzia Anna Maria, Mazzuccato, Giorgia, Carnazzo, Valeria, Pignalosa, Stefano, Di Biase, Luigi, Marino, Mariapaola, Basile, Umberto, Rosato, Edoardo, Callà, Cinzia Anna Maria (ORCID:0000-0001-7962-1229), Marino, Mariapaola (ORCID:0000-0001-9155-6378), Pellicano, Chiara, Colalillo, Amalia, Cusano, Giuseppina, Palladino, Andrea, Pellegrini, Marica, Calla', Cinzia Anna Maria, Mazzuccato, Giorgia, Carnazzo, Valeria, Pignalosa, Stefano, Di Biase, Luigi, Marino, Mariapaola, Basile, Umberto, Rosato, Edoardo, Callà, Cinzia Anna Maria (ORCID:0000-0001-7962-1229), and Marino, Mariapaola (ORCID:0000-0001-9155-6378)

Abstract

Objectives: To assess serum immunoglobulin G (IgG) subclasses in a cohort of systemic sclerosis (SSc) patients and to evaluate the influence of IgG subclasses in the main complications of the disease. Methods: The serum level of IgG subclasses was evaluated in 67 SSc patients and 48 healthy controls (HC), matched for sex and age. Serum samples were collected and measured IgG1-4 subclasses by turbidimetry. Results: SSc patients had lower median total IgG [9.88 g/l (IQR 8.18-11.42 g/l) vs. 12.09 g/l (IQR 10.24-13.54 g/l), p < 0.001], IgG1 [5.09 g/l (IQR 4.25-6.38 g/l) vs. 6.03 g/l (IQR 5.39-7.90 g/l), p < 0.001], and IgG3 [0.59 g/l (IQR 0.40-0.77 g/l) vs. 0.80 g/l (IQR 0.46-1 g/l), p < 0.05] serum levels compared to HC. The logistic regression analysis showed IgG3 as the only variable associated with the diffusing capacity of the lung for carbon monoxide (DLco) ≤60% of the predicted [OR 9.734 (CI 95%: 1.312-72.221), p < 0.05] and modified Rodnan skin score (mRSS) [OR 1.124 (CI 95%: 1.019-1.240), p < 0.05], anti-topoisomerase I [OR 0.060 (CI 95%: 0.007-0.535), p < 0.05], and IgG3 [OR 14.062 (CI 95%: 1.352-146.229), p < 0.05] as variables associated with radiological interstitial lung disease (ILD). Conclusion: SSc patients have reduced levels of total IgG and an altered IgG subclass distribution compared to HC. Moreover, SSc patients show different serum IgG subclasses profiles according to the main involvement of the disease.

Published
2023

45. Serum Immunoglobulin G (IgG) Subclasses in a Cohort of Systemic Sclerosis Patients

Author

Pellicano, Chiara, primary, Colalillo, Amalia, additional, Cusano, Giuseppina, additional, Palladino, Andrea, additional, Pellegrini, Marica, additional, Callà, Cinzia Anna Maria, additional, Mazzuccato, Giorgia, additional, Carnazzo, Valeria, additional, Pignalosa, Stefano, additional, Di Biase, Luigi, additional, Marino, Mariapaola, additional, Basile, Umberto, additional, and Rosato, Edoardo, additional

Published
2023
Full Text
View/download PDF

46. Contrast-induced acute kfunction. The role of vascular and biochemical parameters

Author

Perrotta, ADOLFO MARCO, Gigante, Antonietta, Rotondi, Silverio, Paolo, Menè, Notturni, Adriano, Schiavetto, Stefano, Tanzilli, Gaetano, Pellicano, Chiara, Guaglianone, Giuseppe, Tinti, Francesca, Palange, Paolo, Mazzaferro, Sandro, Cianci, Rosario, and Lai, Silvia

Subjects
serum uric acid, contrast-induced acute kidney injury, renal resistivity index, intima-media thickness, c reactive protein, percutaneous coronary interventions
Published
2023

47. Might IgA be a Biomarker of Disease Activity in Takayasu Arteritis?

Author

Marcella Visentini Marcella Visentini, Giuseppina Cusano Giuseppina Cusano, Marzia Miglionico Marzia Miglionico, Chiara Pellicano Chiara Pellicano, and Lorenzo Vantaggio

Subjects
Internal Medicine
Abstract

Takayasu arteritis is a systemic vasculitis of the large vessels and mainly affects Japanese and Southeast Asian women in the second and third decades of life. Inflammatory infiltrate affects the full thickness of the vessel wall, inducing progressive lumen stenosis and occlusion. The main biomarkers of disease activity are the ESR, CRP and serum levels of circulating cytokines. This case report describes the clinical history of a young woman with Takayasu disease with high serum levels of IgA at onset. IgA remained elevated with persistence of disease activity, and normalized only when the patient was treated with an anti-TNF agent (infliximab), which also induced a clinical response in the vasculitis. IgA levels, together with other inflammatory parameters, may be considered a biomarker of disease activity.

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results